Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophysical methods combined with genetic engineering is used to understand the solution properties of the formulation. The latter has become very important since many indications such as arthritis and asthma require the development of formulations for subcutaneous delivery (SC). The development of formulations for IV delivery is also important and comes with a different set of challenges. The challenges and strategies that can overcome these limitations are discussed in this book, starting with an introduction to these issues, followed by chapters detailing strategies to deal with them. Subsequent chapters explore the processing and storage of mAbs, development of delivery device technologies and conclude with a chapter on the future of mAbs in therapeutic remedies. Discusses the challenges to develop MAbs for intravenous (IV) and subcutaneous delivery (SC) Presents strategies to meet the challenges in development of MAbs for SC and IV administration Discusses the use of biophysical analytical tools coupled with MAb engineering to understand what governs MAb properties at high concentration
Titus, J. A., Haugland, R., Sharrow, S. O. and Segal, D. M. (1982) Texas Red, a hydrophilic, red-emitting fluorophore ... I. A., Wellems, T. E. McCutchan, T. F., Szarfman, A., London, W. T., Corcoran, L. M., Burkot, T. R. and Carter, ...
A sample of the most exciting developments in the cloning, manipulation, expression and application of genetically-engineered monoclonal antibodies.
This volume serves as a follow-up to our previous book, MonoclonalAntibodies Hybridomas: A New Dimension in Biological Analyses.
This book represents the distillation and critical evaluation of many hundreds of publications relating to the production and use of antibodies. Therefore it is restricted to the "core" techniques of...
Gey, M. Instrumentelle Analytik und Bioanalytik. Biosubstanzen, Trennmethoden, Strukturanalytik, Applikationen; Springer: Berlin/Heidelberg, Germany, 2008. Kong, H.; Ye, F.; Lu, X.; Guo, L.; Tian, J.; Xu, G. Deconvolution of overlapped ...
The committee held an open data-gathering meeting during which its members summarized data bearing on those questions. A 1-day workshop (Appendix A) was attended by 34 participants, 14 of whom made formal presentations.
At the time Kohler and Milstein introduced this new technology, the editors of this volume were involved in the production of antisera against differentiation antigens (K. B. B. ), histocompatibility antigens (T. ].
Lindquist K. J., Coleman, R. E., and Osterland, C. K., 1970, Autoantibodies in chronic pulmonary tuberculosis, J. Chronic Dis. , 22:717. Lotte, A., Wasz-Hockert O. , Poisson N., and Dumitrescu, D., ...
This edition includes new chapters covering the key steps to generate high quality monoclonals via different methods, from antigen generation to epitope mapping and quality control of the purified IgG.
This highly practical book, and successor to Volume 13 in the Laboratory Techniques series, explores further and provides more comprehensive, autoritative information on the production of Mabs.